Intellia Therapeutics (NTLA) Earnings
|
Expand Research on NTLA
| Next EPS Date | 7/30/26 | EPS Growth Rate | +17.3% |
|---|---|---|---|
| Average EPS % Beat Rate | +9.6% | Revenue Growth Rate | -7.7% |
| Average % Move 1-Wk after EPS | -6.6% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
7/30/26  |
Q226 | N/A | -$0.81 | N/A | N/A | $13.15M | N/A | N/A | N/A | ||
| 5/11/26 |
Q126 | -$0.81 | -$0.91 | +$0.10 | $15.04M | $13.51M | N/A |  | | Details | |
| 5/5/26 |
Q126 | N/A | -$0.91 | N/A | N/A | $13.51M | N/A | N/A | N/A | ||
| 5/4/26 |
Q126 | N/A | -$0.91 | N/A | N/A | $13.51M | N/A | N/A | N/A | ||
| 5/1/26 |
Q126 | N/A | -$0.91 | N/A | N/A | $13.51M | N/A | N/A | N/A | ||
| 4/30/26 |
Q126 | N/A | -$0.91 | N/A | N/A | $13.51M | N/A | N/A | N/A | ||
| 2/26/26 | Q425 | -$0.83 | -$0.96 | +$0.13 | N/A | $12.08M | N/A | | | Details | |
| 2/19/26 |
Q425 | N/A | -$0.96 | N/A | N/A | $12.08M | N/A | N/A | N/A |
